Skip to content
10-K

Annual Report

NEUROPACE, INC. NPCE

0001528287-25-000007

← back to feed
Filed
Mar 4, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Feb 28, 2025 32.56M sh
Sga Expense FY 2024 · Dec 31, 2024 $57.1M
Sga Expense FY 2024 · Dec 31, 2023 $54.52M
Shares Diluted FY 2024 · Dec 31, 2023 25.85M sh
Capex FY 2024 · Dec 31, 2023 $173K
Operating Cash Flow FY 2024 · Dec 31, 2023 −$19.7M
Long Term Debt FY 2024 · Dec 31, 2023 $56.95M
Short Term Investments FY 2024 · Dec 31, 2023 $48.4M
Cash And Equivalents FY 2024 · Dec 31, 2023 $18.06M
Current Liabilities FY 2024 · Dec 31, 2023 $16.23M
Total Liabilities FY 2024 · Dec 31, 2023 $87M
Current Assets FY 2024 · Dec 31, 2023 $92.72M
Total Assets FY 2024 · Dec 31, 2023 $107.65M
Eps Diluted FY 2024 · Dec 31, 2023 −$1.27
Eps Basic FY 2024 · Dec 31, 2023 −$1.27
Rd Expense FY 2024 · Dec 31, 2023 $20.78M
Net Income FY 2024 · Dec 31, 2023 −$32.96M
Operating Income FY 2024 · Dec 31, 2023 −$27.17M
Gross Profit FY 2024 · Dec 31, 2023 $48.12M
Cost Of Revenue FY 2024 · Dec 31, 2023 $17.3M
Revenue FY 2024 · Dec 31, 2023 $65.42M
Stockholders Equity FY 2024 · Dec 31, 2022 $34.78M